| Brokerage Reports (Showing 1 to 10 of 10) |
Release Date ![[down]](http://us.i1.yimg.com/us.yimg.com/i/fi/down.gif) |
Contributor |
Author |
Title |
Pages |
Price |
StarMine Author Rating | More Info |
| EPS Accuracy * |
Portfolio Return ** |
| 29-Oct-09 | Emerging Growth Equities , Ltd. | Raymond A. Myers CFA | RTIX: recovery losing momentum. | 7 | $25 | | | View Abstract |
| 29-Oct-09 | Roth Capital Partners, Inc. | Research Department | Morning Call Summary | 20 | $50 | | | View Abstract |
| 29-Oct-09 | Roth Capital Partners, Inc. | Matt Dolan | RTIX: Good 3Q Helped by Surgical Sales; Signs of Stabilization Coming; Hold | 7 | $25 | | | View Abstract |
| 28-Oct-09 | Thomson StreetEvents | N/A | RTIX - Event Transcript of RTI Biologics, Inc. conference call, Oct. 28, 2009 / 9:00am ET | 18 | $75 | | | View Abstract |
| 27-Oct-09 | Roth Capital Partners, Inc. | Matt Dolan | RTI Biologics (RTIX) 3Q09 Earnings Preview | 3 | $10 | | | View Abstract |
| 27-Oct-09 | Roth Capital Partners, Inc. | Research Department | Morning Call Summary | 10 | $25 | | | View Abstract |
| 15-Oct-09 | Roth Capital Partners, Inc. | Research Department | Morning Call Summary | 14 | $50 | | | View Abstract |
| 14-Oct-09 | Roth Capital Partners, Inc. | Matt Dolan | 3Q09 Medical Device Earnings Preview: Part 1 | 6 | $25 | | | View Abstract |
| 12-Oct-09 | Roth Capital Partners, Inc. | Research Department | Morning Call Summary | 13 | $50 | | | View Abstract |
| 9-Oct-09 | Roth Capital Partners, Inc. | Matt Dolan | 3Q 2009: Quarterly Medical Device Trading & Acquisition Valuation Update | 8 | $25 | | | View Abstract |